Concepedia

Phase II Trial of Amsacrine Plus Intermediate-dose Ara-C (IDAC) with or without Etoposide as Salvage Therapy for Refractory or Relapsed Acute Leukemia

Woo Jin Sung, Dong Hwan Kim, Sang Kyun Sohn, Jong Gwang Kim, Jin Ho Baek, Seok Bong Jeon, Joon Ho Moon, Byung Min Ahn, Kyu Bo Lee

Japanese Journal of Clinical Oncology · 2005 · 21 citations · 20 references

DOIFull text

Open access

Abstract

A salvage therapy consisting of amsacrine plus IDAC with or without etoposide appears to be safe and an effective bridge therapy into a stem cell transplantation programme for patients with refractory or relapsed acute leukemia.

References

20

Arabinosyl Cytosine: A Useful Agent in the Treatment of Acute Leukemia in Adults

Rose Ruth Ellison, James F. Holland, Marise Weil et al. · Blood · 1968 · 548 citations · Full text

Randomized Comparison of DAT Versus ADE as Induction Chemotherapy in Children and Younger Adults With Acute Myeloid Leukemia. Results of the Medical Research Council's 10th AML Trial (MRC AML10)

Ian Hann, Richard Stevens, Anthony H. Goldstone et al. · Blood · 1997 · 301 citations · Full text

High-dose cytosine arabinoside therapy with and without anthracycline antibiotics for remission reinduction of acute nonlymphoblastic leukemia.

R H Herzig, Hillard M. Lazarus, Steven N. Wolff et al. · Journal of Clinical Oncology · 1985 · 182 citations

, , +17

The experimental antitumour properties of three congeners of the acridylmethanesulphonanilide (AMSA) series

B. F. CAIN, Graham J. Atwell · European Journal of Cancer (1965) · 1974 · 158 citations

, , +3

Failure of remission induction in acute myelocytic leukemia

Harvey D. Preisler · Medical and Pediatric Oncology · 1978 · 143 citations

, , +6